因自发性颅内出血入住ICU患者的结果与费用
该研究为健康行政数据库的回顾性队列分析,纳入同一医院系统两个ICU在2011至2014年间收治的8,447例患者,其中332例诊断为自发性颅内出血,并按年龄、性别和合并症指数1:4随机匹配非颅内出血ICU患者作为对照。颅内出血患者平均年龄60.1岁,120例(36.1%)在出院前死亡;颅内出血患者平均总费用为75,869美元,对照组为52,471美元(p<0.01),存活者平均费用为118,813美元。蛛网膜下腔出血平均总费用高于脑出血(92,794美元 vs 53,491美元,p<0.01),日均费用也更高(4,377美元 vs 3,604美元,p<0.01);口服抗凝药相关颅内出血平均总费用为152,373美元,非口服抗凝药相关者为66,548美元(p<0.01)。作者结论认为,ICU颅内出血患者费用高、病死率高,导致存活者人均费用升高。
要点
- 332例ICU自发性颅内出血患者中120例(36.1%)出院前死亡,平均年龄60.1岁。
- 颅内出血患者平均总费用75,869美元,对照组52,471美元(p<0.01);存活者平均费用118,813美元。
- 蛛网膜下腔出血平均总费用92,794美元,高于脑出血的53,491美元(p<0.01)。
- 口服抗凝药相关颅内出血平均总费用152,373美元,非口服抗凝药相关者为66,548美元(p<0.01)。
- 颅内出血存活至出院者平均费用100,979美元,高于死亡者的30,872美元(p<0.01)。
适用人群与场景
- 2011至2014年入住同一医院系统两个ICU的成人患者,其中332例诊断为自发性颅内出血(包括蛛网膜下腔出血和脑出血)。
- 对照为随机选取的年龄、性别和合并症指数匹配的非颅内出血ICU患者,匹配比例1:4。
研究设计与关键结果
- 研究类型为健康行政数据库的回顾性队列分析,纳入8,447例ICU患者,其中332例自发性颅内出血,对照按1:4匹配。
- 颅内出血患者平均年龄60.1岁,120例(36.1%)出院前死亡。
- 颅内出血患者平均总费用75,869美元,对照组52,471美元(p<0.01);颅内出血存活者平均费用118,813美元。
- 蛛网膜下腔出血平均总费用92,794美元,高于脑出血的53,491美元(p<0.01);蛛网膜下腔出血平均每日费用4,377美元,高于脑出血的3,604美元(p<0.01)。
- 颅内出血存活至出院者平均总费用100,979美元,高于死亡者的30,872美元(p<0.01)。
- 口服抗凝药相关颅内出血平均总费用152,373美元,非口服抗凝药相关颅内出血为66,548美元(p<0.01)。
证据类型、等级与局限
- 证据类型:回顾性队列分析(健康行政数据库)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU自发性颅内出血患者费用高、病死率高,导致存活者人均费用升高;蛛网膜下腔出血患者费用高于脑出血患者,口服抗凝药相关脑出血费用尤其高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Spontaneous intracranial hemorrhage, including subarachnoid hemorrhage and intracerebral hemorrhage, is associated with significant morbidity and mortality. Although many of these patients will require ICU admission, little is known regarding their outcomes and the costs incurred. We evaluated this population in order to identify outcomes and cost patterns.
DESIGN: Retrospective cohort analysis of a health administrative database.
SETTING: Two ICUs within a single hospital system.
PATIENTS: Eight-thousand four-hundred forty-seven patients admitted to ICU from 2011 to 2014, of whom 332 had a diagnosis of spontaneous intracranial hemorrhage. Control patients were defined as randomly selected age, sex, and comorbidity index-matched nonintracranial hemorrhage ICU patients (1:4 matching ratio).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Mean age of ICU intracranial hemorrhage patients was 60.1 years, and 120 (36.1%) died prior to discharge. Intracranial hemorrhage was associated with a mean total cost of $75,869, compared with $52,471 in control patients (p < 0.01). Mean cost per survivor of intracranial hemorrhage patients was $118,813. Subarachnoid hemorrhage was associated with significantly higher mean total costs than intracerebral hemorrhage ($92,794 vs $53,491; p < 0.01) and higher mean cost per day ($4,377 vs $3,604; p < 0.01). Patients with intracranial hemorrhage who survived to hospital discharge were significantly costlier than decedents ($100,979 vs $30,872; p < 0.01). Intracranial hemorrhage associated with oral anticoagulant use had a mean total cost of $152,373, compared with $66,548 in nonoral anticoagulant intracranial hemorrhage (p < 0.01).
CONCLUSIONS: Patients admitted to ICU with intracranial hemorrhage have high costs and high mortality, leading to elevated cost per survivor. Subarachnoid hemorrhage patients incur greater costs than intracerebral hemorrhage patients, and oral anticoagulant-associated intracerebral hemorrhage is particularly costly. Our findings provide novel information regarding financial impact of this common ICU population.
参考来源
- Fernando SM, Reardon PM, Dowlatshahi D, et al. Outcomes and Costs of Patients Admitted to the ICU Due to Spontaneous Intracranial Hemorrhage. Crit Care Med. 2018. PMID: 29406421. doi:10.1097/CCM.0000000000003013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。